NO20060557L - CCK-1 reseptormodulator - Google Patents
CCK-1 reseptormodulatorInfo
- Publication number
- NO20060557L NO20060557L NO20060557A NO20060557A NO20060557L NO 20060557 L NO20060557 L NO 20060557L NO 20060557 A NO20060557 A NO 20060557A NO 20060557 A NO20060557 A NO 20060557A NO 20060557 L NO20060557 L NO 20060557L
- Authority
- NO
- Norway
- Prior art keywords
- cck
- receptor modulator
- group
- bonding
- hydrocarbon
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Det er tilveiebrakt ved foreliggende fremgangsmåte visse pyrazolbaserte CCK-1-reseptor-modulatorer som har den generelle formelen: hvori Ar er en aromatisk eller heteroaromatisk gruppe, X er en hydrokarbonbindingsgruppe, Y er en binding eller hydrokarbonbindingsgruppe og R1, R2, R3 , R4 og R5 er visse organiske substituenter, og fremgangsmåter for fremstilling av samme.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48431903P | 2003-07-02 | 2003-07-02 | |
US48437003P | 2003-07-02 | 2003-07-02 | |
PCT/US2004/021020 WO2005005393A2 (en) | 2003-07-02 | 2004-06-30 | Cck-1 receptor modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20060557L true NO20060557L (no) | 2006-03-23 |
Family
ID=34068191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20060557A NO20060557L (no) | 2003-07-02 | 2006-02-02 | CCK-1 reseptormodulator |
Country Status (13)
Country | Link |
---|---|
US (1) | US20050026903A1 (no) |
EP (1) | EP1641762A2 (no) |
JP (1) | JP2007521301A (no) |
KR (1) | KR20060030506A (no) |
AR (1) | AR045003A1 (no) |
AU (1) | AU2004256106A1 (no) |
BR (1) | BRPI0412269A (no) |
CA (1) | CA2530737A1 (no) |
IL (1) | IL172921A0 (no) |
NO (1) | NO20060557L (no) |
RU (1) | RU2005141571A (no) |
TW (1) | TW200524876A (no) |
WO (1) | WO2005005393A2 (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050020565A1 (en) * | 2003-07-02 | 2005-01-27 | Jones Todd K. | CCK-1 receptor modulators |
US8524302B2 (en) | 2009-11-02 | 2013-09-03 | Pepsico | Natural flavour enhancers and methods for making same |
EP2688890B1 (en) | 2011-03-22 | 2017-08-30 | Advinus Therapeutics Limited | Substituted fused tricyclic compounds, compositions and medicinal applications thereof |
JP2015529242A (ja) | 2012-09-21 | 2015-10-05 | アドヴィヌス セラピューティクス リミテッドAdvinus Therapeutics Limited | 置換された縮合三環式化合物、組成物およびその医薬用途 |
CN109020913A (zh) * | 2017-06-12 | 2018-12-18 | 上海百灵医药科技有限公司 | 一种酰基化硫代恶唑烷酮的合成方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5164381A (en) * | 1986-05-29 | 1992-11-17 | Ortho Pharmaceutical Corporation | Pharmacologically active 1,5-diaryl-3-substituted pyrazoles and method for synthesizing the same |
US4826868A (en) * | 1986-05-29 | 1989-05-02 | Ortho Pharmaceutical Corporation | 1,5-Diaryl-3-substituted pyrazoles pharmaceutical compositions and use |
US5051518A (en) * | 1987-05-29 | 1991-09-24 | Ortho Pharmaceutical Corporation | Pharmacologically active 2- and 3-substituted (1',5'-diaryl-3-pyrazolyl)-N-hydroxypropanamides |
AU6490396A (en) * | 1995-07-14 | 1997-02-18 | Smithkline Beecham Corporation | Substituted-pent-4-ynoic acids |
DE19621687A1 (de) * | 1996-05-30 | 1997-12-04 | Bayer Ag | Verfahren zur Herstellung von substituierten Arylpyrazolen |
NZ513831A (en) * | 1999-03-03 | 2001-09-28 | Procter & Gamble | Alkenyl- and alkynyl-containing metalloprotease inhibitors |
WO2003024958A2 (en) * | 2001-09-18 | 2003-03-27 | Onconova Therapeutics, Inc. | Processes for the preparation of 1,5-diaryl-3-substituted-pyrazoles |
UA79804C2 (en) * | 2002-07-03 | 2007-07-25 | Janssen Pharmaceutica Nv | Cck-1 receptor modulators |
US20050020565A1 (en) * | 2003-07-02 | 2005-01-27 | Jones Todd K. | CCK-1 receptor modulators |
US7620632B2 (en) * | 2004-06-30 | 2009-11-17 | Skyler Technology, Inc. | Method and/or system for performing tree matching |
CN101023062A (zh) * | 2004-06-30 | 2007-08-22 | 詹森药业有限公司 | 由立体有择性脱水制造α,β-不饱和酯和酸 |
-
2004
- 2004-06-30 BR BRPI0412269-0A patent/BRPI0412269A/pt not_active IP Right Cessation
- 2004-06-30 RU RU2005141571/04A patent/RU2005141571A/ru not_active Application Discontinuation
- 2004-06-30 US US10/881,628 patent/US20050026903A1/en not_active Abandoned
- 2004-06-30 JP JP2006518735A patent/JP2007521301A/ja not_active Withdrawn
- 2004-06-30 KR KR1020067000064A patent/KR20060030506A/ko not_active Application Discontinuation
- 2004-06-30 AU AU2004256106A patent/AU2004256106A1/en not_active Abandoned
- 2004-06-30 EP EP04756436A patent/EP1641762A2/en not_active Withdrawn
- 2004-06-30 CA CA002530737A patent/CA2530737A1/en not_active Abandoned
- 2004-06-30 WO PCT/US2004/021020 patent/WO2005005393A2/en active Application Filing
- 2004-07-01 TW TW093119876A patent/TW200524876A/zh unknown
- 2004-07-02 AR ARP040102344A patent/AR045003A1/es not_active Application Discontinuation
-
2005
- 2005-12-29 IL IL172921A patent/IL172921A0/en unknown
-
2006
- 2006-02-02 NO NO20060557A patent/NO20060557L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL172921A0 (en) | 2006-06-11 |
WO2005005393A3 (en) | 2005-02-24 |
BRPI0412269A (pt) | 2006-09-05 |
CA2530737A1 (en) | 2005-01-20 |
KR20060030506A (ko) | 2006-04-10 |
US20050026903A1 (en) | 2005-02-03 |
AR045003A1 (es) | 2005-10-12 |
TW200524876A (en) | 2005-08-01 |
RU2005141571A (ru) | 2007-07-10 |
AU2004256106A1 (en) | 2005-01-20 |
EP1641762A2 (en) | 2006-04-05 |
JP2007521301A (ja) | 2007-08-02 |
WO2005005393A2 (en) | 2005-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20081231L (no) | Kondenserte heterocykliske forbindelser anvendbare som kinasemodulatorer | |
MX2019005777A (es) | Compuestos de n-(3fluoropropil)-pirrolidina sustituidos novedosos, procesos para su preparacion y usos terapeuticos de los mismos. | |
NO20051270L (no) | Sammensmeltet benzenderivat og anvendelse | |
NO20060426L (no) | Kannabinoid reseptormodulator | |
WO2004096757A8 (en) | Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators | |
NO20060557L (no) | CCK-1 reseptormodulator | |
NO20051328L (no) | Kalsiumreseptormodulerende forbindelse og anvendelse derav | |
NO982850L (no) | Ny syntese | |
BRPI0615705A2 (pt) | processo para preparar um composto, e, composto | |
EA201000883A1 (ru) | Производные индолинона и способ их получения | |
GEP20125572B (en) | Use of spiroheterocyclic pyrrolidine dione derivatives as pesticides | |
NO20075706L (no) | Pyrrolopyridinbaserte inhibitorer av dipeptidylpeptidase IV og metoder | |
CR9660A (es) | Nuevo derivado de heterocicliden acetamida | |
WO2005070893A3 (en) | Azadecalin glucocorticoid receptor modulators | |
BRPI0411268C8 (pt) | Processo para a preparação de compostos 3-aril butil-amina substituído | |
WO2008096127A3 (en) | Bicyclo[2.2.1]hept-7-ylamine derivatives and their use as m3 muscarinic receptor modulators | |
EA201070246A1 (ru) | Циклические аминные соединения | |
WO2007062190A3 (en) | Chemical compounds | |
ATE446753T1 (de) | Verwendung von substituierten 2-thio-3,5-dicyano- 4-phenyl-6-aminopyridinen bei der behandlung von übelkeit und erbrechen | |
WO2009075890A8 (en) | Method for synthesis of triazole compounds that modulate hsp90 activity | |
GB0411929D0 (en) | Organic compounds | |
ATE399775T1 (de) | Triphenylethyleneverbindungen als selektive modulatoren des östrogenrezeptors | |
DK1838670T3 (da) | Fremgangsmåde til fremstilling af carvedilol og dets enantiomere | |
NO20070428L (no) | Alfa, beta-umettede estere og syrer ved stereoselektiv dehydrering | |
ATE486854T1 (de) | Herstellung von uretdion-polyisocyanaten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |